These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Additional endovascular therapy in patients with acute ischemic stroke who are nonresponsive to intravenous tissue plasminogen activator: usefulness of magnetic resonance angiography-diffusion mismatch. Dembo T, Deguchi I, Fukuoka T, Nagoya H, Maruyama H, Kato Y, Horiuchi Y, Ohe Y, Tanahashi N. J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1056-63. PubMed ID: 22902147 [Abstract] [Full Text] [Related]
9. Fluid-Attenuated Inversion Recovery Vascular Hyperintensities-Diffusion-Weighted Imaging Mismatch Identifies Acute Stroke Patients Most Likely to Benefit From Recanalization. Legrand L, Tisserand M, Turc G, Edjlali M, Calvet D, Trystram D, Roca P, Naggara O, Mas JL, Méder JF, Baron JC, Oppenheim C. Stroke; 2016 Feb; 47(2):424-7. PubMed ID: 26732567 [Abstract] [Full Text] [Related]
10. Sensitivity of diffusion- and perfusion-weighted imaging for diagnosing acute ischemic stroke is 97.5%. Simonsen CZ, Madsen MH, Schmitz ML, Mikkelsen IK, Fisher M, Andersen G. Stroke; 2015 Jan; 46(1):98-101. PubMed ID: 25388415 [Abstract] [Full Text] [Related]
12. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry. Deguchi I, Dembo T, Yoshimura S, Sakai N, Okada Y, Kitagawa K, Kimura K, Hyogo T, Yamagami H, Egashira Y, Tanahashi N. J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994 [Abstract] [Full Text] [Related]
16. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window. Sølling C, Hjort N, Ashkanian M, Østergaard L, Andersen G. Cerebrovasc Dis; 2009 Apr; 27(3):223-9. PubMed ID: 19176954 [Abstract] [Full Text] [Related]
17. Magnetic resonance imaging indexes of therapeutic efficacy of recombinant tissue plasminogen activator treatment of rat at 1 and 4 hours after embolic stroke. Jiang Q, Zhang RL, Zhang ZG, Ewing JR, Jiang P, Divine GW, Knight RA, Chopp M. J Cereb Blood Flow Metab; 2000 Jan; 20(1):21-7. PubMed ID: 10616789 [Abstract] [Full Text] [Related]
18. [ASPECTS-DWI, arterial occlusion sites and subtype of acute ischemic stroke have a relation with outcome following intravenous rt-PA therapy]. Idei M, Sasaki T, Tanabe T, Muraoka K, Terada K, Meguro T, Hirotsune N, Nishino S. No Shinkei Geka; 2012 Jul; 40(7):585-91. PubMed ID: 22728535 [Abstract] [Full Text] [Related]
19. Optimizing discharge planning: clinical predictors of longer stay after recombinant tissue plasminogen activator for acute stroke. Saposnik G, Webster F, O'Callaghan C, Hachinski V. Stroke; 2005 Jan; 36(1):147-50. PubMed ID: 15569861 [Abstract] [Full Text] [Related]
20. Fluctuation of diffusion-weighted imaging and apparent diffusion coefficient in acute stroke following tissue plasminogen activator administration. Chertcoff AS, Chomont J, Bandeo L, Pantiu F, Roca CU, Bonardo P, Rugilo C, Reisin R. Neurol India; 2017 Jan; 65(4):889-890. PubMed ID: 28681774 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]